Dr. Jie Zheng's lab focuses on advancing cardiac imaging techniques, particularly using magnetic resonance imaging (MRI) to assess how much oxygen the heart muscles extract from the blood. They develop innovative methods that are non-invasive and do not expose patients to harmful radiation, making them safer and potentially more available than existing techniques like PET scans. The lab's research not only aims to improve diagnostic capabilities for heart diseases but also to provide insights into treatment responses for various cardiac conditions.

Dr. Jil Tardiff's lab at the University of Arizona focuses on understanding hypertrophic cardiomyopathy (HCM), a genetic heart condition caused by mutations in the heart's contractile proteins. The lab investigates how these mutations affect heart function, particularly diastolic relaxation. By using advanced techniques, they aim to identify potential therapeutic targets for early treatment, which could significantly improve patient outcomes.

Dr. Adam W. Anderson’s lab at Vanderbilt University focuses on improving the technology and methods used in diffusion MRI to better visualize and understand brain structures. By developing advanced techniques for analyzing MRI data, the lab works to enhance the sensitivity and accuracy of brain imaging, which is vital for diagnosing and monitoring brain disorders. Their research not only aims to refine these imaging techniques but also strives to link MRI findings with the underlying biophysical properties of brain tissues, which will ultimately aid in patient care.

Dr. Margot S. Damaser’s lab focuses on developing innovative treatments for pelvic organ prolapse (POP), a condition that affects many women and can significantly impact their quality of life. The lab's main project investigates a novel drug delivery system using biodegradable nanomaterials to restore the elasticity of pelvic tissues, potentially preventing the progression of POP without invasive surgery. By combining advanced biomaterials with therapeutic agents, the lab aims to create effective and minimally invasive solutions for better women's health outcomes.

Wendy E Thomas's lab at the University of Washington studies how certain bacteria, specifically oral streptococci, contribute to a serious heart infection called infective endocarditis. Her research focuses on how these bacteria interact with sugars on human cells, which influences their ability to cause infection. By understanding these interactions better, the lab aims to find new strategies for preventing and treating this life-threatening condition.

Dr. Sana D Karam's lab at Washington University focuses on understanding how estrogen influences cancer treatment, particularly in head and neck cancer (HNSCC), which affects more men than women. The lab investigates the roles of specific immune cells and hormonal signaling in response to therapies, aiming to enhance treatment outcomes for women, especially those who are premenopausal. Research explores how estrogen can alter immune responses and tumor environments to better tailor cancer therapies based on sex and hormonal status.

Dr. Kooresh Isaac Shoghi's lab focuses on improving treatment options for patients with advanced breast cancer by studying how certain therapies work with estrogen receptors. Specifically, they investigate the use of PET imaging to predict which patients might benefit from hormone therapies instead of more aggressive treatments like chemotherapy. This research aims to make cancer treatment more personalized and effective for patients with hormone-sensitive breast cancer.

Dr. Constantinos Koumenis' lab at the University of Pennsylvania focuses on improving radiation therapy for cancer patients. They are studying a new technique called FLASH radiotherapy, which uses a high dose of radiation to minimize damage to healthy tissues while effectively targeting tumors. Their research aims to understand how this innovative approach can protect normal tissues during treatments for various cancers, including pancreatic and lung cancer.

Deepak Vashishth's lab focuses on understanding how specific compounds in bone, particularly those formed during diabetes, affect fracture risk. They study advanced glycation end products (AGEs) like carboxymethyl-lysine (CML) to see how they alter bone quality and contribute to fragility fractures, especially in people with type 2 diabetes. The research could lead to better ways to predict and manage fractures in diabetic patients.

Dr. Shanshan Jiang's lab at Johns Hopkins University focuses on improving the diagnosis and treatment monitoring of glioblastoma, a highly aggressive brain tumor. The research combines innovative liquid biopsy techniques, analyzing circulating tumor DNA, with advanced MRI imaging to provide real-time insights into how well patients are responding to treatment. This work aims to develop non-invasive methods that could spare many patients from unnecessary surgeries and lead to more personalized treatment strategies.

Dr. Christopher Chad Quarles' research lab focuses on improving the diagnosis and treatment of brain tumors, particularly gliomas. The lab is working on two main projects: refining an MRI imaging protocol to better assess brain tumors and developing mathematical models to predict how individual tumors respond to therapies. These efforts aim to enhance patient management by providing more accurate tools for clinicians.

The lab focuses on developing new biomaterial scaffolds designed to enhance the healing process of diabetic wounds. By engineering a special type of hydrogel called Microporous Annealed Particle gel (MAP gel), the team aims to reduce inflammation, improve tissue integration, and support better blood vessel formation in wounds. With a combination of in vitro and in vivo experiments, they work to systematically improve these hydrogels for effective treatment alternatives for diabetic patients.

Dr. Arash Kheradvar's lab focuses on innovative heart valve tissue engineering and understanding the mechanics of heart function in diseases like pulmonary arterial hypertension. His research aims to develop living tissue valves that can better mimic native heart valves and to non-invasively monitor right ventricle function in patients with heart disease. They aim to improve patient outcomes by enhancing the performance and longevity of heart valves and utilizing advanced imaging techniques for clinical monitoring.

Dr. Junjie Chen's lab at the University of Texas MD Anderson Cancer Center focuses on understanding how cells repair DNA damage and the role of specific enzymes in cancer treatment. They explore the mechanisms behind DNA topoisomerases, which are crucial for managing DNA structure during crucial cellular processes. The lab aims to develop improved cancer therapies by targeting DNA repair pathways and enhancing the effectiveness of current treatment strategies.

Dr. Jing Hong Wang's lab at the University of Pittsburgh focuses on understanding how head and neck cancer that is associated with human papillomavirus (HPV) responds to immunotherapy. The team studies the immune system's reaction to HPV antigens and how different T cell receptors impact treatment effectiveness. Their research aims to improve therapies for patients with HPV-positive cancers by exploring the mechanisms driving treatment resistance and response.

Dr. Nicholas C. Denko's lab focuses on improving treatments for non-small cell lung cancer (NSCLC) by addressing the challenge of tumor hypoxia. They explore how reducing oxygen demand in tumors can enhance the effects of existing therapies like radiation and immunotherapy. The lab investigates novel derivatives of papaverine, an FDA-approved drug, to assess their potential in overcoming resistance to these treatments.

Dr. Xavier Intes's research lab focuses on advancing the field of molecular imaging in cancer treatment. They are developing an innovative imaging platform that combines advanced technology and artificial intelligence to visualize how drugs interact with tumors in real time. This work aims to improve the effectiveness of targeted drug therapies by providing a detailed understanding of tumor biology and drug distribution.

Dr. Liang Gao's lab at UCLA focuses on advanced imaging techniques to study heart and brain activity in real time. The research uses innovative optical methods, particularly in zebrafish models and neuronal networks, to explore the underlying mechanisms of cardiac arrhythmias like atrial fibrillation and the dynamics of neuronal signaling. This work has the potential to enhance our understanding of heart conditions and neuronal behavior at the cellular level.

Dr. Harrison Kim's lab at Ohio State University focuses on improving treatment strategies for patients with borderline resectable pancreatic cancer. They utilize advanced imaging techniques, specifically dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), to evaluate how well patients respond to chemotherapy before surgical intervention. This innovative approach aims to enhance surgical outcomes and ensure patients receive the most effective therapy early in the treatment process.

Dr. Elizabeth Mcdonald's lab at the University of Pennsylvania focuses on improving cancer treatment through innovative imaging techniques. The lab is developing a new PET imaging method that can predict how well patients with breast cancer will respond to specific therapies using PARP inhibitors. This research aims to personalize cancer treatments and reduce unnecessary side effects by matching patients with the most effective therapies based on their tumor characteristics.